Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
First Test Concor · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| First Test Concor (Fasted), Then Reference Concor (Fasted) | EXPERIMENTAL | Participants will receive a single oral dose of Test Concor tablet on Day 1 in treatment period 1 followed by single oral dose of reference Concor tablet on Day 8 in treatment period 2 under fasted condition. There will be separate washout period of 7 days between each treatment period. |
| First Reference Concor (Fasted), Then Test Concor (Fasted) | EXPERIMENTAL | Participants will receive a single oral dose of Reference Concor tablet on Day 1 in treatment period 1 followed by single oral dose of Test Concor tablet on day 8 in treatment period 2 under fasted condition. There will be separate washout period of 7 days between each treatment period. |
| First Test Concor (Fed), Then Reference Concor (Fed) | EXPERIMENTAL | Participants will receive a single oral dose of Test Concor tablet on Day 1 in treatment period 1 followed by a single oral dose of Reference Concor tablet on Day 8 in treatment period 2 under fed condition. There will be separate washout period of 7 days between each treatment period. |
| First Reference Concor (Fed), Then Test Concor (Fed) | EXPERIMENTAL | Participants will receive a single oral dose of Reference Concor tablet on Day 1 in treatment period 1 followed by a single oral dose of Test Concor tablet on Day 8 in treatment period 2 under fed condition. There will be separate washout period of 7 days between each treatment period. |
| Name | Type | Description |
|---|---|---|
| First Test Concor (Fasted) | DRUG | Participants will receive single oral dose of Test Concor tablet under fasted or fed condition. |
| First Reference Concor (Fasted) | DRUG | Participants will receive single oral dose of Reference Concor tablet under fasted or fed condition |
| First Test Concor (Fed) | DRUG | Participants will receive single oral dose of Test Concor tablet under fasted or fed condition. |
| First Reference Concor (Fed) | DRUG | Participants will receive single oral dose of Reference Concor tablet under fasted or fed condition. |
Inclusion Criteria: * Participants are overtly healthy as determined by medical evaluation, including medical history, physical examination, laboratory tests and cardiac monitoring * Participant must have a body weight within 50-90 kilogram (kg) and body mass index (BMI) within the range 19-26 kilo...
First Test Concor is an investigational small molecule developed by Merck KGaA. It has been studied in a Phase 1 bioequivalence trial in healthy adult participants in China. The specific therapeutic indication for First Test Concor has not been disclosed.
First Test Concor is developed by Merck KGaA, which trades under the ticker MKGAF. The company sponsored the clinical trial evaluating the drug candidate.
First Test Concor is in Phase 1 clinical development. It is investigational and has been evaluated in one completed Phase 1 trial. There are currently no active trials of First Test Concor listed.
First Test Concor has been studied in one completed Phase 1 trial, NCT05930808, titled Concor Bioequivalence Study in Chinese Participants (Darmstadt-Nantong). The trial enrolled 46 healthy adult volunteers in China, was randomized and controlled, and included both male and female participants aged 18 years and older.
Yes, First Test Concor (Fasted) is another name for First Test Concor. Both names refer to the same investigational drug candidate developed by Merck KGaA.